BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23238104)

  • 1. Oxytocin modulates dopamine-mediated reward in the rat subthalamic nucleus.
    Baracz SJ; Cornish JL
    Horm Behav; 2013 Feb; 63(2):370-5. PubMed ID: 23238104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Involvement of Oxytocin in the Subthalamic Nucleus on Relapse to Methamphetamine-Seeking Behaviour.
    Baracz SJ; Everett NA; Cornish JL
    PLoS One; 2015; 10(8):e0136132. PubMed ID: 26284529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference.
    Baracz SJ; Rourke PI; Pardey MC; Hunt GE; McGregor IS; Cornish JL
    Behav Brain Res; 2012 Mar; 228(1):185-93. PubMed ID: 22155611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats.
    Baracz SJ; Everett NA; McGregor IS; Cornish JL
    Addict Biol; 2016 Mar; 21(2):316-25. PubMed ID: 25399704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin enhances the expression of morphine-induced conditioned place preference in rats.
    Moaddab M; Hyland BI; Brown CH
    Psychoneuroendocrinology; 2015 Mar; 53():159-69. PubMed ID: 25618594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus.
    Carson DS; Hunt GE; Guastella AJ; Barber L; Cornish JL; Arnold JC; Boucher AA; McGregor IS
    Addict Biol; 2010 Oct; 15(4):448-63. PubMed ID: 20731630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Methamphetamine Self-Administration Dysregulates Oxytocin Plasma Levels and Oxytocin Receptor Fibre Density in the Nucleus Accumbens Core and Subthalamic Nucleus of the Rat.
    Baracz SJ; Parker LM; Suraev AS; Everett NA; Goodchild AK; McGregor IS; Cornish JL
    J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26563756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats.
    Sellings LH; McQuade LE; Clarke PB
    Neuroscience; 2006 Sep; 141(3):1457-68. PubMed ID: 16753267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement.
    Qi J; Yang JY; Wang F; Zhao YN; Song M; Wu CF
    Neuropharmacology; 2009 Apr; 56(5):856-65. PubMed ID: 19371575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats.
    Tan SE
    Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rewarding properties of methylphenidate: sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists.
    Meririnne E; Kankaanpää A; Seppälä T
    J Pharmacol Exp Ther; 2001 Aug; 298(2):539-50. PubMed ID: 11454915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
    Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C
    J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of conditioned place preference induced by intra-accumbens infusion of amphetamine is attenuated by co-infusion of dopamine D1 and D2 receptor antagonists.
    Liao RM
    Pharmacol Biochem Behav; 2008 May; 89(3):367-73. PubMed ID: 18275994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of D1/D2 dopamine receptors in the CA1 region of the rat hippocampus in the rewarding effects of morphine administered into the ventral tegmental area.
    Esmaeili MH; Kermani M; Parvishan A; Haghparast A
    Behav Brain Res; 2012 May; 231(1):111-5. PubMed ID: 22426507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
    Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
    Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of D2 dopamine receptors in oxytocin induced place preference and anxiolytic effect.
    László K; Péczely L; Géczi F; Kovács A; Zagoracz O; Ollmann T; Kertes E; Kállai V; László B; Berta B; Karádi Z; Lénárd L
    Horm Behav; 2020 Aug; 124():104777. PubMed ID: 32439347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin in the rat caudate nucleus influences pain modulation.
    Yang J; Pan YJ; Zhao Y; Qiu PY; Lu L; Li P; Chen F; Yan XQ; Wang DX
    Peptides; 2011 Oct; 32(10):2104-7. PubMed ID: 21903147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oxytocin receptor impairs ethanol reward in mice.
    Bahi A
    Physiol Behav; 2015 Feb; 139():321-7. PubMed ID: 25449413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats.
    Melis MR; Melis T; Cocco C; Succu S; Sanna F; Pillolla G; Boi A; Ferri GL; Argiolas A
    Eur J Neurosci; 2007 Aug; 26(4):1026-35. PubMed ID: 17672853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histaminergic receptors of medial septum and conditioned place preference: D1 dopamine receptor mechanism.
    Zarrindast MR; Moghimi M; Rostami P; Rezayof A
    Brain Res; 2006 Sep; 1109(1):108-16. PubMed ID: 16828718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.